GRANULES vs INDSWFTLAB: Stock Comparison

GRANULES INDIA vs IND SWIFT LABORATORIES LTUpdated 4 Sept 26, 4:08 PM ISTNSE & company filings

GRANULES INDIA is the larger company by market capitalisation. GRANULES INDIA shows a lower P/E, a higher ROE and a higher dividend yield, while IND SWIFT LABORATORIES LT shows lower leverage and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

GRANULES leads 8; INDSWFTLAB leads 5 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

GRANULESINDSWFTLAB

Valuation lens

What price are you paying?

Market CapContext only
₹21,073 Cr
₹3,048 Cr
P/E RatioGRANULES has the lower reading
31.03x
54.27x
P/B RatioINDSWFTLAB has the lower reading
4.08x
2.29x
EPSGRANULES has the higher reading
₹2.9
₹2.84
Book ValueContext only
₹205.21
₹159.15
Dividend YieldGRANULES has the higher reading
0.21%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
GRANULES is the larger company
₹21,073 Cr vs ₹3,048 Cr
P/E Ratio
GRANULES has a lower P/E
31.03x vs 54.27x
P/B Ratio
INDSWFTLAB has a lower P/B
2.29x vs 4.08x
EPS
GRANULES has higher earnings per share
₹2.9 vs ₹2.84
Dividend Yield
GRANULES has a higher dividend yield
0.21% vs 0%
Revenue Growth (TTM YoY)
GRANULES has faster revenue growth
22.8% vs -66.6%
EPS Growth (TTM YoY)
GRANULES has faster EPS growth
31.3% vs -94.8%
Qtr Sales Growth
INDSWFTLAB has stronger quarterly sales growth
2.89% vs -45.7%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricGRANULESINDSWFTLAB
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricGRANULESINDSWFTLAB
Live Price₹848.3₹355.95
Day Change-0.65%-4.49%
Volume11.73 L6.95 L
52-Week High₹910₹389.5
52-Week Low₹507.3₹87.15
Distance from 52W High-6.78%-8.61%

Valuation

MetricGRANULESINDSWFTLAB
Market Cap₹21,073 Cr₹3,048 Cr
P/E Ratio31.03x54.27x
P/B Ratio4.08x2.29x
EPS₹2.9₹2.84
Book Value₹205.21₹159.15
Dividend Yield0.21%0%

Growth

MetricGRANULESINDSWFTLAB
Revenue Growth (TTM YoY)22.8%-66.6%
EPS Growth (TTM YoY)31.3%-94.8%
Qtr Sales Growth-45.7%2.89%
Qtr Profit Growth-60.13%0.98%

Profitability & Leverage

MetricGRANULESINDSWFTLAB
ROE11.7%3.1%
ROCE12.47%5.3%
Net Margin11.15%41.4%
Operating Margin16.76%8.32%
Debt to Equity0.26x0.01x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricGRANULESINDSWFTLAB
Promoter Holding37.67%42.93% 0.06 pp
FII Holding17.5% 2.19 pp10.7% 3.18 pp
DII Holding16.11% 0.9 pp0.17% 0.17 pp
Public Holding28.38% 1.28 pp46.2% 3.08 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: GRANULES INDIA and IND SWIFT LABORATORIES LT.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.